Abstract:The transcription factor p53 is under negative regulation by the ubiquitin ligase MDM2 and its close homologue MDM4. In the bound complex between MDM2 and p53, the transactivation domain of p53 adopts an amphipathic helical conformation which optimizes the spatial organization of three key hydrophobic residues (Phe19, Trp23, Leu26) for maximum interactions. The interaction with MDM2 is known to be abrogated by phosphorylation of Ser/Thr residues in the MDM2 N-terminal domain and in the p53 transactivation domain. In the latter, phosphorylation of Thr18 has been attributed to destabilize a key hbond between Thr18 and Asp21. This interaction has been thought to be critical for the formation of the helical conformation of the p53 transactivation domain. Molecular dynamics simulations of the p53 transactivation domain suggest that phosphorylation of either Thr18 or Ser20 does not disrupt its helical structure but does result in reduced affinities for MDM2. While interactions between the Thr18 and Asp21 are indeed broken due to charge-charge repulsions, the peptide has enough inherent flexibility to form alternate patterns of hbonds, resulting in the maintenance of helicity. Electrostatics of MDM2 reveal local anionic patches in the region where Thr18 docks. These suggest that repulsions will arise because the MDM2 surface will force the p53 to bind in a manner that will place the negatively charged phosphorylated Thr18 near this anionic region. A similar, albeit somewhat attenuated pattern of electrostatic modulations, is seen for a model of MDM4 that has been built. Mutants of MDM2 and MDM4 have been designed to attenuate this anionicity and have been computationally demonstrated to enhance the binding of the phosphorylated peptides.

The SWIB/MDM2 motif of UBE4B activates the p53 pathway.

UBE4B targets phosphorylated p53 at serines 15 and 392 for degradation

Inhibition of Nonsense-Mediated Decay Rescues P53β/γ Isoform Expression and Activates the P53 Pathway in MDM2-overexpressing and Select P53-Mutant Cancers

Inhibition of nonsense-mediated decay rescues p53/ isoform expression and activates the p53 pathway in and select-mutant cancers

Inhibition of Nonsense-Mediated Decay Rescues Functional P53β/γ Isoforms in MDM2-amplified Cancers

The E3 Ligase Ring1 Targets P53 For Degradation And Promotes Cancer Cell Proliferation And Survival

Small Molecule Inhibitors of the P53-Mdm2

The Wip1 Phosphatase And Mdm2: Cracking The "Wip" On P53 Sta

The Wip1 Phosphatase and Mdm2: Cracking the "wip" on P53 Stability.

Stabilization of Mdm2 Via Decreased Ubiquitination is Mediated by Protein Kinase B/Akt-dependent Phosphorylation

Modulation of the p53-MDM2 Interaction by Phosphorylation of Thr18: A Computational Study

Small molecule inhibitors of HDM2 ubiquitin ligase activity stabilize and activate p53 in cells

Smad Ubiquitylation Regulatory Factor 1/2 (Smurf1/2) Promotes p53 Degradation by Stabilizing the E3 Ligase MDM2

UBTD1 Induces Cellular Senescence Through an UBTD1-Mdm2/p53 Positive Feedback Loop.

The Janus Face of P53-Targeting Ubiquitin Ligases

Butein inhibits cancer cell growth by rescuing the wild-type thermal stability of mutant p53

The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop.

Usp4 Inhibits P53 Through Deubiquitinating and Stabilizing Arf-Bp1

Targeting USP2 regulation of VPRBP-mediated degradation of p53 and PD-L1 for cancer therapy

USP10 Regulates p53 Localization and Stability by Deubiquitinating p53

Negative Regulation Of Hdm2 To Attenuate P53 Degradation By Ribosomal Protein L26